reported that TXNIP antisense cDNA transfection in melanoma cells reduced FasL and CD44 cytokine expression, confirming TXNIP’s role in promoting melanoma cell apoptosis and inhibiting tumor growth (63). This evidence concerns the gene FASLG and neoplasm.